Lataa...
Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study
BACKGROUND: Secondary prevention of atrial fibrillation (AF) could be carried out by means of antiarrhythmic drugs; however this strategy has not received any endorsement because these drugs are burdened by a high risk of proarrhythmic events (flecainide, sotalol) or extracardiac effects (amiodarone...
Tallennettuna:
| Julkaisussa: | Cardiol Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elmer Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681845/ https://ncbi.nlm.nih.gov/pubmed/31413779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/cr909 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|